Table 7.
Complications |
SCXL N = 91 |
ACXL N = 92 |
TCXL N = 88 |
Management | Fate |
---|---|---|---|---|---|
Photophobia, pain and watery eyes | 37 (40.7%) | 28 (30.4%) | 2 (2.3%) |
|
Resolved in 24–48 hours |
Delay in epithelial healing | 17 (18.7%) | 4 (4.3%) | zero (0.0%) |
|
All eyes showed complete re‐epithelization in the 2nd week except 2 eyes in SCXL group |
Persistent epithelial defect (PED) | 2 (2.2%) | zero (0.0%) | zero (0.0%) |
|
One eye showed complete re‐epithelization with haze in the 3rd month. The other eye herald with remaining corneal oedema, haze and opacification |
Corneal stromal opacity | 1 (1.1%) | zero (0.0%) | zero (0.0%) |
|
The condition ended in permanent central corneal stromal opacity after 6 months with final CDVA 1.2 logMAR (preoperative CDVA 0.4 logMAR) |
Corneal haze |
57 (62.6%):
|
21 (22.8%):
|
zero (0.0%) |
|
All eyes showed complete recovery within 6 months except one eye in SCXL group that ended in permanent stromal opacity |
KC progression | zero (0.0%) | 5 (5.4%) | 25 (28.4%) |
|
The retreated eyes showed good stability till the end of the study |